Drug Landscape ›
Frozen plasma ›
Regulatory · United States
Marketing authorisation
FDA
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
Window: 20 April 2025 – 20 April 2026
Total reports: 2,647
Most-reported reactions
Renal Failure — 329 reports (12.43%) Pain — 328 reports (12.39%) Injury — 304 reports (11.48%) Unevaluable Event — 296 reports (11.18%) Anxiety — 273 reports (10.31%) Fear — 254 reports (9.6%) Renal Impairment — 240 reports (9.07%) Renal Injury — 219 reports (8.27%) Emotional Distress — 210 reports (7.93%) Stress — 194 reports (7.33%)
Source database →
Frozen plasma in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Frozen plasma approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for Frozen plasma in United States?
Ottawa Hospital Research Institute is the originator. The local marketing authorisation holder may differ — check the official source linked above.